4597.T
Price:
$29
Market Cap:
$7.42B
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 a chemotherapy induced peripheral neur...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-03-27
Stock Exchange
JPX
Ticker
4597.T
According to Solasia Pharma K.K.’s latest financial reports and current stock price. The company's current PE Ratio is -3.24. This represents a change of -58.66% compared to the average of -7.84 of the last 4 quarters.
The mean historical PE Ratio of Solasia Pharma K.K. over the last ten years is -12.21. The current -3.24 PE Ratio has changed 2.55% with respect to the historical average. Over the past ten years (40 quarters), 4597.T's PE Ratio was at its highest in in the September 2017 quarter at 53.70. The PE Ratio was at its lowest in in the December 2016 quarter at -308.21.
Average
-12.21
Median
-6.21
Minimum
-32.10
Maximum
-2.92
Discovering the peaks and valleys of Solasia Pharma K.K. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 132.79%
Maximum Annual PE Ratio = -2.92
Minimum Annual Increase = -82.85%
Minimum Annual PE Ratio = -32.10
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.68 | -45.84% |
| 2023 | -6.80 | 132.79% |
| 2022 | -2.92 | -48.01% |
| 2021 | -5.62 | 70.41% |
| 2020 | -3.30 | -68.18% |
| 2019 | -10.37 | 88.36% |
| 2018 | -5.50 | -82.85% |
| 2017 | -32.10 | 55.06% |
| 2016 | -20.70 | -33.37% |
| 2015 | -31.07 | 5.15% |
The current PE Ratio of Solasia Pharma K.K. (4597.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.47
5-year avg
-4.47
10-year avg
-12.21
Solasia Pharma K.K.’s PE Ratio is greater than MedRx Co., Ltd (-5.15), less than Morishita Jintan Co., Ltd. (15.17), less than Data Horizon Corporation (-2.94), less than Modalis Therapeutics Corporation (-1.95), greater than Chordia Therapeutics Inc. (-4.09), greater than ADR120S, Inc. (-4.04), less than SymBio Pharmaceuticals Limited (-0.94), greater than BrightPath Biotherapeutics Co., Ltd. (-4.87), greater than Chiome Bioscience Inc. (-8.04), greater than OncoTherapy Science, Inc. (-7.72),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.15 | $6.24B | |
| 15.17 | $8.80B | |
| -2.94 | $6.42B | |
| -1.95 | $4.00B | |
| -4.09 | $7.31B | |
| -4.04 | $7.42B | |
| -0.94 | $4.54B | |
| -4.87 | $4.35B | |
| -8.04 | $7.28B | |
| -7.72 | $6.77B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solasia Pharma K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Solasia Pharma K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Solasia Pharma K.K.'s PE Ratio?
How is the PE Ratio calculated for Solasia Pharma K.K. (4597.T)?
What is the highest PE Ratio for Solasia Pharma K.K. (4597.T)?
What is the 3-year average PE Ratio for Solasia Pharma K.K. (4597.T)?
What is the 5-year average PE Ratio for Solasia Pharma K.K. (4597.T)?
How does the current PE Ratio for Solasia Pharma K.K. (4597.T) compare to its historical average?